Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04278833Phase 4Terminated
Phase 4, randomised, single-blind trial of triamcinolone, betamethasone and dexamethasone in osteoarthritis (OA), tendinopathy and shoulder impingement syndrome (SIS) (2 arms), sponsored by Stanford University. Primary endpoints: Mean Change in Average Pain From Baseline at 6 months and Number of Participants With ≥50% Decrease in Pain From Baseline at 6 months. Started Sep 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04278833.